Skip to main content
SpringerLink
Log in

Model estimates prevalence of catastrophic costs of TB

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Sweeney S, et al. Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa. PharmacoEconomics : 2 Apr 2020. Available from: URL: https://doi.org/10.1007/s40273-020-00898-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Model estimates prevalence of catastrophic costs of TB. PharmacoEcon Outcomes News 851, 31 (2020). https://doi.org/10.1007/s40274-020-6754-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6754-0

Search

Navigation